1. Home
  2. ALC

as 05-30-2024 12:02pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Ophthalmic Goods

Nasdaq

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Founded: 1945 Country:
Switzerland
Switzerland
Employees: 25315 City: N/A
Market Cap: 43.5B IPO Year: N/A
Target Price: $95.82 AVG Volume (30 days): 874.9K
Analyst Decision: Strong Buy Number of Analysts: 12
Dividend Yield: 0.30% Dividend Payout Frequency: Annual
EPS: 2.11 EPS Growth: 210.29
52 Week Low/High: $69.44 - $91.08 Next Earning Date: 05-13-2024
Revenue: $9,562,000,000 Revenue Growth: 7.68%
Revenue Growth (this year): 6.58% Revenue Growth (next year): 6.54%

ALC Daily Stock ML Predictions

Share on Social Networks: